MOUNTAIN VIEW, Calif., Feb. 3, 2021 /PRNewswire/ -- Turn Biotechnologies, a company developing medicines for currently untreatable age-related conditions, announced that it has acquired the global rights for new artificial niche (AN) technology that can be used to restore muscle stem cells damaged by aging. The company licensed its AN technology from Stanford University, where it […]
